Bulletin
Investor Alert

New York Markets Open in:

BioVaxys Technology Corp.

CNQ: CA:BIOV

GO

/zigman2/quotes/209221990/delayed

$

0.28

Change

-0.02 -5.17%

Volume

Volume 194,100

Nov 30, 2021, 3:59 p.m.

Quotes are delayed by 15 min

/zigman2/quotes/209221990/delayed

Previous close

$ 0.29

$ 0.28

Change

-0.02 -5.17%

Day low

Day high

$0.28

$0.31

Open
Open: 0.30

52 week low

52 week high

$0.14

$0.78

Open

Market cap

$21.62M

Average volume

327,634

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.06

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/ca/biov

MarketWatch News on BIOV

No News currently available for BIOV

/news/nonmarketwatch/company/ca/biov

Other News on BIOV

  1. Stocks in play: BioVaxys Technology Corp.

    9:14 a.m. Nov. 9, 2021

    - Baystreet.ca

  2. Are We Coming to the End of Using the PCR Covid-19 Test?

    9:22 a.m. Oct. 20, 2021

    - Baystreet.ca

  3. Stocks in play: BioVaxys Technology Corp.

    8:35 a.m. Oct. 20, 2021

    - Baystreet.ca

  4. Stocks in play: BioVaxys Technology Corp.

    8:54 a.m. Sept. 23, 2021

    - Baystreet.ca

  5. Stocks in play: BioVaxys Technology Corp.

    8:44 a.m. Sept. 17, 2021

    - Baystreet.ca

  6. Loading more headlines...
/news/pressrelease/company/ca/biov

Press Releases on BIOV

  1. Are We Coming to the End of Using the PCR Covid-19 Test?

    8:27 a.m. Oct. 20, 2021

    - Baystreet.ca

  2. BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine

    7:19 a.m. Oct. 20, 2021

    - Financial News Media

  3. BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine

    7:00 a.m. Oct. 20, 2021

    - PR Newswire - PRF

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.